Acelyrin, Inc.(SLRN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SLRN Acelyrin, Inc.

盘前交易 12-19 06:42:04 EST

3.27

-0.23

-6.57%

最高3.60	最低3.14	成交量108.75万
今开3.54	昨收3.50	日振幅13.14%
总市值3.28亿	流通市值1.97亿	总股本1.00亿
成交额357.65万	换手率1.81%	流通股本6,022万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SLRN","market":"US","secType":"STK","nameCN":"Acelyrin, Inc.","latestPrice":3.27,"timestamp":1734555600000,"preClose":3.5,"halted":0,"volume":1087519,"delay":0,"floatShares":60221235,"shares":100325569,"eps":-2.680881,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.23,"latestTime":"12-19 06:42:04 EST","open":3.54,"high":3.6,"low":3.14,"amount":3576505.2474769996,"amplitude":0.131429,"askPrice":5.23,"askSize":200,"bidPrice":2.89,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-2.680881,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734618600000},"adr":0,"listingDate":1683259200000,"adjPreClose":3.27,"postHourTrading":{"tag":"盘后","latestPrice":3.09,"preClose":3.27,"latestTime":"17:44 EST","volume":1645,"amount":5275.22,"timestamp":1734561864662},"volumeRatio":0.7551093101966173,"impliedVol":1.9449,"impliedVolPercentile":0.8048},"requestUrl":"/m/hq/s/SLRN/wiki","defaultTab":"wiki","newsList":[{"id":"2491769963","title":"Acelyrin, Inc.盘中异动 股价大跌5.08%报3.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491769963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491769963?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:44","pubTimestamp":1734101084,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时44分，Acelyrin, Inc.股票出现波动，股价大幅下跌5.08%。截至发稿，该股报3.36美元/股，成交量2.013万股，换手率0.02%，振幅3.67%。Acelyrin, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213224444a1ec392f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213224444a1ec392f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2490681358","title":"Acelyrin, Inc.股价重挫16.01% 市值跌5477.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490681358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490681358?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:32","pubTimestamp":1733927531,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时32分，Acelyrin, Inc.股票出现波动，股价大幅跳水16.01%。截至发稿，该股报3.41美元/股，成交量9.7954万股，换手率0.10%，振幅4.43%。Acelyrin, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为367.17%、108.25%、97.36%，振幅较大的相关个股有Candel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.、Tnf Pharmaceuticals, Inc.，振幅分别为36.44%、18.52%、18.15%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223211a1e66b03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223211a1e66b03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2490881009","title":"美国研究综述-ICU Medical、Lennar Corp、Sweetgreen","url":"https://stock-news.laohu8.com/highlight/detail?id=2490881009","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490881009?lang=zh_cn&edition=full","pubTime":"2024-12-11 15:32","pubTimestamp":1733902364,"startTime":"0","endTime":"0","summary":"美国研究综述-ICU Medical、Lennar Corp、Sweetgreen路透12月11日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 ICU Medical、Lennar Corp 和 Sweetgreen。* ICU Medical Inc ICUI.O：杰富瑞将其评级从 \"持有 \"上调至 \"买入 * Lennar Corp LEN.N：巴克莱将其从增持下调至增持 * Sweetgreen Inc SG.N：KeyBanc给予其行业增持评级 * Taylor Morrison Home Corp TMHC.N：巴克莱将其评级从增持上调至增持以下是路透周三报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4T3NC0H5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AJG","BK4182","BK4104","LU0154245673.USD","IQV","QURE","ALK","LU1989763427.SGD","IE00B19Z4B17.USD","OC","PRIM","SIRI","LU0320765489.SGD","LU0528227936.USD","SW","LEN","IE00BVYPNW00.USD","SG","TMHC","BK4198","SNV","PHM","AZPN","BK4566","KVUE","LU0157215616.USD","EPAM","BK4183","DHI","GEV","BK4082","OLLI","LU2125910336.SGD","PLAY","KBH","FWONA","LU0240877869.USD","FERG","BK4561","ICUI","LU0048578792.EUR","QTTB","LU0240878834.USD","TMDX","BK4548","MAX","SLRN","IE00B7SZL793.SGD"],"gpt_icon":1},{"id":"2490088100","title":"美国研究综述-ICU Medical、Lennar Corp、Sweetgreen","url":"https://stock-news.laohu8.com/highlight/detail?id=2490088100","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490088100?lang=zh_cn&edition=full","pubTime":"2024-12-11 15:32","pubTimestamp":1733902364,"startTime":"0","endTime":"0","summary":"    路透12月11日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 ICU Medical、Lennar Corp 和 Sweetgreen。* ICU Medical Inc   ：杰富瑞将其评级从 \"持有 \"上调至 \"买入             * Lennar Corp   ：巴克莱将其从增持下调至增持             * Sweetgreen Inc   ：KeyBanc给予其行业增持评级             * Taylor Morrison Home Corp   ：巴克莱将其评级从增持上调至增持 以下是路透周三报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861165.SGD","OLLI","TMDX","LU2045819591.USD","TMHC","QURE","AJG","IE00B66KJ199.SGD","PHM","SW","LU1093756168.USD","KVUE","BK4558","LU2242646821.SGD","SNV","LU1261432733.SGD","OC","ALK","GEV","FERG","MAX","DHI","ICU","IQV","QTTB","LEN","KBH","BK4183","AZPN","LU0823411888.USD","PLAY","LU0320765489.SGD","LU0654597011.USD","LU1920062954.HKD","LU1803068623.USD","BK4134","ICUI","LU2023250504.SGD","LU1923621640.USD","SLRN","LU0550127509.SGD","SG9999015945.SGD","EPAM","LU0868494617.USD","SIRI","SG","PRIM","LU1363072403.SGD"],"gpt_icon":1},{"id":"2490203400","title":"BUZZ-眼科药物研究失败，Acelyrin 下跌，首席财务官辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2490203400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490203400?lang=zh_cn&edition=full","pubTime":"2024-12-11 06:39","pubTimestamp":1733870370,"startTime":"0","endTime":"0","summary":"    12月10日 - ** 药物开发商Acelyrin Inc   股价盘后下跌16.5%至3.38美元** SLRN称 ，其实验性药物zokibep未能达到针对葡萄膜炎患者的中后期研究的主要目标。** 补充说，公司将不再为开发 izokibep 增加内部投资** 将专注于开发另一种治疗甲状腺眼病的药物 lonigutamab** 另外，首席财务官 Gil Labrucherie 已通知公司，他打算从 2025 年 1 月 2 日起辞职，以寻求外部机会，文件  显示。** 截至上一交易日收盘，股价累计下跌约 45","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2488461509","title":"Acelyrin, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488461509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488461509?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:44","pubTimestamp":1733237057,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时44分，Acelyrin, Inc.股票出现异动，股价急速下挫5.03%。截至发稿，该股报4.25美元/股，成交量6341股，换手率0.01%，振幅2.01%。Acelyrin, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为132.89%、79.70%、67.61%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.、Senti Biosciences, Inc.，振幅分别为51.13%、34.31%、28.00%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224418abf2ff71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224418abf2ff71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2488677311","title":"Acelyrin, Inc.盘中异动 股价大涨5.49%报4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488677311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488677311?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:38","pubTimestamp":1733150306,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时38分，Acelyrin, Inc.股票出现异动，股价快速上涨5.49%。截至发稿，该股报4.80美元/股，成交量1.6483万股，换手率0.02%，振幅4.84%。Acelyrin, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Senti Biosciences, Inc.、Purple Biotech Ltd、Revelation Biosciences, Inc.较为活跃，换手率分别为813.15%、730.29%、208.61%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Senti Biosciences, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为64.17%、49.54%、31.58%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223826a2669ce5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223826a2669ce5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2486175038","title":"Acelyrin, Inc.盘中异动 早盘急速上涨5.11%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486175038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486175038?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:39","pubTimestamp":1732545587,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时39分，Acelyrin, Inc.股票出现波动，股价急速拉升5.11%。截至发稿，该股报4.94美元/股，成交量1.1739万股，换手率0.01%，振幅2.55%。Acelyrin, Inc.股票所在的生物技术行业中，整体涨幅为1.29%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Mural Oncology Plc涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为91.02%、68.74%、43.36%，振幅较大的相关个股有Kodiak Sciences Inc、Werewolf Therapeutics, Inc.、Anixa Biosciences, Inc.，振幅分别为106.46%、105.79%、105.63%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223947abddfea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223947abddfea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2485298028","title":"Acelyrin, Inc.2024财年第三财季实现净利润-48.55百万美元，同比增加42.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298028?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:00","pubTimestamp":1732291249,"startTime":"0","endTime":"0","summary":"11月23日，Acelyrin, Inc.公布财报，公告显示公司2024财年第三财季净利润为-48.55百万美元，同比增加42.16%；其中营业收入为0.00美元，每股基本收益为-0.49美元。从资产负债表来看，Acelyrin, Inc.总负债90.03百万美元，其中短期债务0.00美元，资产负债比为0.07，流动比率为0.08。机构评级：截至2024年11月23日，当前有6家机构对Acelyrin, Inc.目标价做出预测，其中目标均价为11.17美元，其中最低目标价为6.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000102abd7b813&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000102abd7b813&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN"],"gpt_icon":0},{"id":"2485261260","title":"Acelyrin, Inc.盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485261260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485261260?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:48","pubTimestamp":1732286914,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时48分，Acelyrin, Inc.股票出现波动，股价大幅上涨5.08%。截至发稿，该股报4.55美元/股，成交量2.0923万股，换手率0.02%，振幅5.77%。Acelyrin, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Virpax Pharmaceuticals, Inc.、Replimune Group, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Molecular Templates, Inc.、Aptose Biosciences, Inc.较为活跃，换手率分别为1018.38%、72.09%、25.48%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为44.82%、33.00%、30.69%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224834971a81bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224834971a81bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2484609152","title":"Acelyrin, Inc.盘中异动 大幅跳水5.01%报4.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484609152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484609152?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:42","pubTimestamp":1731951757,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时42分，Acelyrin, Inc.股票出现异动，股价大幅下跌5.01%。截至发稿，该股报4.46美元/股，成交量23.7964万股，换手率0.24%，振幅6.82%。Acelyrin, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Hcw Biologics Inc.、冠科美博、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Hcw Biologics Inc.、冠科美博、Tharimmune, Inc.较为活跃，换手率分别为1106.86%、696.59%、565.76%，振幅较大的相关个股有Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为563.48%、129.51%、91.09%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119014237971a73ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119014237971a73ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2483804293","title":"Acelyrin, Inc.盘中异动 大幅下跌5.35%报5.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483804293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483804293?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:37","pubTimestamp":1731595027,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时37分，Acelyrin, Inc.股票出现波动，股价快速下跌5.35%。截至发稿，该股报5.66美元/股，成交量4.2343万股，换手率0.04%，振幅7.53%。Acelyrin, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1640.97%、22.97%、15.89%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Pds Biotechnology Corporation，振幅分别为75.00%、38.46%、26.13%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223707971a68fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223707971a68fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2483050876","title":"美国研究综述-思科、Freshpet、Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2483050876","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483050876?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:06","pubTimestamp":1731585982,"startTime":"0","endTime":"0","summary":"美国研究综述-思科、Freshpet、Nvidia路透11月14日 - 华尔街证券分析师周四调整了对思科、Freshpet 和 Nvidia 等几家美国上市公司的评级和目标价。要闻 * 思科CSCO.O：杰富瑞将目标价从53美元上调至66美元 * Freshpet Inc FRPT.O：奥本海默将目标价从155美元上调至180美元  * ICU Medical Inc ICUI.O：Raymond James将目标价从190美元上调至205美元  * Kronos Bio Inc KRON.O：TD Cowen将目标价从买入下调至持有 * Nvidia Corp NVDA.O：奥本海默将目标价从 150 美元上调至 175 美元 以下是路透周四报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML18A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COGT","APEI","AROC","LU1244550577.SGD","ALMS","CHX","IE00BFXG1179.USD","CSCO","CAVA","AMGN","CAKE","AIT","ALLO","BIIB","CPB","DOX","LU1894683348.USD","BK4209","CHGG","LU0234572021.USD","LU0300736492.USD","SLRN","LU1244550494.USD","LU0868494708.USD","AESI","CPAY","BPMC","BKR","CPT","ADAP","CTRA","BWXT","CNNE","ACRV","CRVS","FDMT","CBSH","SG9999002232.USD","ALSN","BRBR","AVB","IE00BZ1G4Q59.USD","BK4550","EE","BTMD","LU2106854487.HKD","APD","AXTA","AZTA","SPRY"],"gpt_icon":0},{"id":"2482123167","title":"ACELYRIN Inc   预计每股亏损80美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482123167","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482123167?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:52","pubTimestamp":1731383549,"startTime":"0","endTime":"0","summary":"   * ACELYRIN公司   将于11月13日公布截至2024年9月30日的财报，预计季度营收将保持不变。*    * LSEG分析师对ACELYRIN公司的平均预期是每股亏损80美分。* 华尔街对 ACELYRIN 公司 12 个月目标价的中位数为 9.00 美元，高于其上次收盘价 6.06 美元。11月12日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ACELYRIN Inc   预计每股亏损80美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLRN"],"gpt_icon":0},{"id":"2479033011","title":"Acelyrin, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479033011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479033011?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:04","pubTimestamp":1730383463,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时04分，Acelyrin, Inc.股票出现波动，股价急速下跌5.08%。截至发稿，该股报5.60美元/股，成交量4.2185万股，换手率0.04%，振幅3.81%。Acelyrin, Inc.股票所在的生物技术行业中，整体跌幅为2.55%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122042398e3fbc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122042398e3fbc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2476736438","title":"Acelyrin, Inc.盘中异动 股价大涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476736438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476736438?lang=zh_cn&edition=full","pubTime":"2024-10-18 03:24","pubTimestamp":1729193049,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日03时24分，Acelyrin, Inc.股票出现异动，股价急速拉升5.43%。截至发稿，该股报6.41美元/股，成交量47.2694万股，换手率0.47%，振幅7.89%。Acelyrin, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Molecular Templates, Inc.、Notable Labs, Ltd.、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Molecular Templates, Inc.、Notable Labs, Ltd.、180 Life Sciences Corp.较为活跃，换手率分别为3162.79%、1354.52%、294.33%，振幅较大的相关个股有Molecular Templates, Inc.、Notable Labs, Ltd.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为259.74%、152.93%、147.48%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101803240998e3d10c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101803240998e3d10c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2475992250","title":"Acelyrin, Inc.盘中异动 股价大涨5.24%报6.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475992250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475992250?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:32","pubTimestamp":1729085520,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时32分，Acelyrin, Inc.股票出现异动，股价大幅拉升5.24%。截至发稿，该股报6.02美元/股，成交量1.9828万股，换手率0.02%，振幅1.92%。Acelyrin, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213200a1e11e9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213200a1e11e9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2473107604","title":"Acelyrin, Inc.盘中异动 早盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473107604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473107604?lang=zh_cn&edition=full","pubTime":"2024-10-07 23:13","pubTimestamp":1728314024,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日23时13分，Acelyrin, Inc.股票出现波动，股价急速跳水5.12%。截至发稿，该股报4.73美元/股，成交量4.9256万股，换手率0.05%，振幅4.52%。Acelyrin, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100723134598e3ae35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100723134598e3ae35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0},{"id":"2472529078","title":"Acelyrin, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472529078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472529078?lang=zh_cn&edition=full","pubTime":"2024-10-02 22:07","pubTimestamp":1727878050,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日22时07分，Acelyrin, Inc.股票出现异动，股价快速下挫5.11%。截至发稿，该股报4.83美元/股，成交量3.2829万股，换手率0.03%，振幅4.52%。Acelyrin, Inc.股票所在的生物技术行业中，整体跌幅为1.42%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Chromocell Therapeutics Corporation涨幅较大，Aditxt, Inc.、Tc Biopharm  Plc、Windtree Therapeutics, Inc.较为活跃，换手率分别为522.67%、27.52%、23.99%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Aditxt, Inc.，振幅分别为145.55%、46.85%、40.28%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022207319719df6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022207319719df6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLRN","BK4139"],"gpt_icon":0},{"id":"2468577021","title":"Acelyrin, Inc.盘中异动 大幅拉升8.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468577021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468577021?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:31","pubTimestamp":1726752671,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时31分，Acelyrin, Inc.股票出现波动，股价大幅拉升8.70%。截至发稿，该股报5.00美元/股，成交量6.1658万股，换手率0.06%，振幅3.04%。Acelyrin, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为1021.42%、333.61%、70.43%，振幅较大的相关个股有Exicure, Inc.、Autolus Therapeutics Plc、Renovaro Inc.，振幅分别为18.34%、11.37%、9.65%。Acelyrin, Inc.公司简介：Acelyrin Inc 是一家后期临床生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213111956fa28d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213111956fa28d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLRN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acelyrin.com","stockEarnings":[{"period":"1week","weight":-0.0411},{"period":"1month","weight":-0.2968},{"period":"3month","weight":-0.383},{"period":"6month","weight":-0.1985},{"period":"1year","weight":-0.568},{"period":"ytd","weight":-0.5617}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acelyrin, Inc于2020年7月27日在美国特拉华州注册成立。Acelyrin, Inc是一家处于后期阶段的生物制药公司，专注于识别、收购和加速变革性药物的开发和商业化。自成立以来，公司投入了几乎所有的资源来组织公司、招聘人员、业务规划、获取和开发其候选产品、进行研发、支持其产品开发工作的制造活动、建立和保护其知识产权组合、筹集资金以及为这些活动提供一般和行政支持。","exchange":"NASDAQ","name":"Acelyrin, Inc.","nameEN":"Acelyrin, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acelyrin, Inc.(SLRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acelyrin, Inc.(SLRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acelyrin, Inc.,SLRN,Acelyrin, Inc.股票,Acelyrin, Inc.股票老虎,Acelyrin, Inc.股票老虎国际,Acelyrin, Inc.行情,Acelyrin, Inc.股票行情,Acelyrin, Inc.股价,Acelyrin, Inc.股市,Acelyrin, Inc.股票价格,Acelyrin, Inc.股票交易,Acelyrin, Inc.股票购买,Acelyrin, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acelyrin, Inc.(SLRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acelyrin, Inc.(SLRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}